CLINICAL TRIALS PROFILE FOR GLOPERBA
✉ Email this page to a colleague
All Clinical Trials for GLOPERBA
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT05739929 ↗ | Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT) | Not yet recruiting | Helwan University | Phase 3 | 2023-03-01 | The goal of this clinical trial is to evaluate the colchicine protective effect in patients undergoing Percutaneous Coronary Intervention (PCI). The main question it aims to answer is: does initiating colchicine before planned PCI will reduce post-procedural myocardial injury? Half of the participants will receive colchicine, while the other half will receive a placebo. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GLOPERBA
Condition Name
Clinical Trial Locations for GLOPERBA
Clinical Trial Progress for GLOPERBA
Clinical Trial Phase
Clinical Trial Sponsors for GLOPERBA
Sponsor Name